Challenging a recent study, an Arizona nutritionist has claimed that vitamin C does not reduce the effectiveness of chemotherapeutic drugs in cancer treatment.
Challenging a recent study, an Arizona nutritionist has claimed that vitamin C does not reduce the effectiveness of chemotherapeutic drugs in cancer treatment.
A study published in Cancer Research concluded that vitamin C, given to mice or cultured cells treated with common anti-cancer drugs, reduces the anti-tumour effects of the chemotherapeutic agents.Jack Challem, a personal nutrition coach and nutrition author from Tucson, Arizona, pointed out two main problems with the study.
The problems were: the oxidized form of vitamin C (dehydroascorbic acid) and not actual vitamin C (ascorbic acid) was used; and in the mouse experiments, the animals were given toxic doses of dehydroascorbic acid, a compound that is not used as a dietary supplement in humans.
"This study and the subsequent headlines [it generated] were a grievous disservice to physicians and patients with cancer," said Challem.
He added: "Considerable positive research...has shown striking benefits from high-dose vitamin C (ascorbic acid) in cancer cells and animals-and in actual human beings."
High-dose intravenous vitamin C is a common form of alternative and complementary therapy for patients receiving chemotherapeutic drugs, and is believed to help bring about tumour cell death.
Advertisement
"The ideal therapeutic approach would be to tailor individual treatment, including IV vitamin C, from a menu of options," suggested Challem.
Advertisement
Source-ANI
SRM